| Specifications | |
|---|---|
| Product type | mRNA |
| Modified bases | Pseudo-UTP |
| 5' Cap | Cap 1 |
| Species | Human |
| RefSeq | NM_001177.6 |
| Applications | Gene therapy research |
| Format | Powder |
| Quantity | 100 µg |
| Purification | Chromatography |
| Target Gene | |
|---|---|
| Gene ID | 400 |
| UniProt ID | P40616 |
| Specifications | |
|---|---|
| Product type | mRNA |
| Modified bases | Pseudo-UTP |
| 5' Cap | Cap 1 |
| Species | Human |
| RefSeq | NM_001177.6 |
| Applications | Gene therapy research |
| Format | Powder |
| Quantity | 100 µg |
| Purification | Chromatography |
| Target Gene | |
|---|---|
| Gene ID | 400 |
| UniProt ID | P40616 |
| Download |
|---|
| Download resources about mRNA therapeutics development to boost your research. |
| CUSTOMER REVIEWS and Q&As | |
|---|---|
|
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARL1, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK25332MR). Click the button above to contact us or submit your feedback about this product. |
|
| See other products | |||
|---|---|---|---|
| CAT | Product Name | Product Type | CDs |
| GTTS-WK5048MR | IVTScrip™ mRNA-Human CD71, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) | mRNA | CD71 |
| GTTS-WK16137MR | IVTScrip™ mRNA-Human ANKRD9, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) | mRNA | ANKRD9 |
| GTTS-WK16730MR | IVTScrip™ mRNA-Human ANKRD50, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) | mRNA | ANKRD50 |
| GTTS-WK22694MR | IVTScrip™ mRNA-Human ASB11, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) | mRNA | ASB11 |
| GTTS-WK20304MR | IVTScrip™ mRNA-Human ANKRD18A, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) | mRNA | ANKRD18A |
| GTTS-WK25995MR | IVTScrip™ mRNA-Human ASB13, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) | mRNA | ASB13 |
| GTTS-WK26111MR | IVTScrip™ mRNA-Human APLNR, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) | mRNA | APLNR |
| GTTS-WK16765MR | IVTScrip™ mRNA-Human ANXA7, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) | mRNA | ANXA7 |